Case Series and Brief Reports
Primary Orbital Cystic Pilocytic AstrocytomaMudhar H.S.a · Nuruddin M.b · Roy S.b
aNational Specialist Ophthalmic Pathology Service (NSOPS), Department of Histopathology, Royal Hallamshire Hospital, Sheffield, UK; bChittagong Eye Infirmary and Training Complex, Chittagong, Bangladesh
Dr. Hardeep Singh Mudhar
National Specialist Ophthalmic Pathology Service (NSOPS)
Department of Histopathology, Royal Hallamshire Hospital
Glossop Road, Shefﬁeld S10 2JF (UK)
Do you have an account?
Purpose: To describe the clinical, radiological and histopathological features of a highly unusual primary orbital glioma. Procedures: A 6-year-old female presented with right-sided proptosis that revealed a well-defined intraconal mass on CT imaging with intact orbital bony walls. During the removal of the lesion, it dissected away freely from the muscles and was separated from the optic nerve and globe. There was no communication with the brain. Results: Histology showed histological features highly favouring a pilocytic astrocytoma enveloped by meninges. No non-neoplastic brain tissue was identified. Conclusion: This is the first documentation of a primary orbital pilocytic astrocytoma not anatomically connected with the brain. We speculate that the tumour had arisen from developmental brain heterotopia.
© 2016 S. Karger AG, Basel
Dutton JJ, Byrne SF, Proia AD: Diagnostic Atlas of Orbital Diseases. Philadelphia, WB Saunders, 2000.
- Shields JA, Shields CL, Scatozzi R: Survey of 1264 patients with orbital tumors and simulating lesions: the 2002 Montgomery Lecture, part 1. Ophthalmology 2004;111:997-1008.
- Czyzyk E, Jozwiak S, Roszkowski M, Schwartz RA: Optic nerve gliomas in children with and without neurofibromatosis 1. J Child Neurol 2003;18:471-478.
- Jones DTW, Kocialkowski S, Liu L, Pearson DM, Bäcklund LM, Ichimura K, Collins VP: Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 2008;68:8673-8677.
- Schindler G, Capper D, Meyer J, Janzarik W, Omran H, Herold-Mende C, Schmieder K, Wesseling P, Mawrin C, Hasselblatt M, Louis DN, Korshunov A, Pfister S, Hartmann C, Paulus W, Reifenberger G, von Deimling A: Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 2011;121:397-405.
- Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA Jr, Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW: An integrated genomic analysis of human glioblastoma multiforme. Science 2008;321:1807-1812.
- Wilkins RB, Hofmann RJ, Byrd WA, Font RL: Heterotopic brain tissue in the orbit. Arch Ophthalmol 1987;105:390-392.
- Newman NJ, Miller NR, Green WR: Ectopic brain in the orbit. Ophthalmology 1986;93:268-272.
- Elder JE, Chow CW, Holmes AD: Heterotopic brain tissue in the orbit: case report. Br J Ophthalmol 1989;73:928-931.
- Scheiner AJ, Frayer WC, Rorke LB, Heher K: Ectopic brain tissue in the orbit. Eye 1999;13:251-254.
- Bruzek A, Shepherd D, Gompel JV, Jentoft M: Pilocytic astrocytoma presenting as an orbital encephalocele: a case report. Case Rep Neurol 2015;7:90-94.
- Ellouze N, Born J, Hoyoux C, Michotte A, Retz C, Tebache M, Piette C: Nasal heterotopia versus pilocytic astrocytoma: a narrow border. Neurochirurgie 2015;61:279-282.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.